Search

everythinglearnresearchcommunity

for

Search:↓

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Using high doses and multiple drugs with steroids is risky and should be prevented.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

Ginsenoside Rg3 combined with minoxidil was more effective in treating hair loss in mice.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.